News

Published on 26 Apr 2024 on Zacks via Yahoo Finance

Arvinas, Inc. (ARVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?


Article preview image

Arvinas, Inc. (ARVN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

NASDAQ.MRNA price evolution
NASDAQ.ARVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.69% By...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.69%

Investing.com 12 Nov 2024

The Week Kamala Harris Lost (Nov 4-8), These Large Cap Stocks Lost Big -...

When Kamala Harris lost the 2024 U.S. election last week, these ten large-cap stocks were the wor...

Benzinga 11 Nov 2024

Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market...

On Thursday, Moderna Inc. (NASDAQ:MRNA) reported third-quarter revenue of $1.83 billion, beating ...

Benzinga · via Yahoo Finance 8 Nov 2024

Moderna adjusts to life after COVID By Proactive Investors

Moderna adjusts to life after COVID

Investing.com 8 Nov 2024

Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks:...

President-elect Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his inc...

Benzinga 7 Nov 2024

Moderna Stock Rises on Q3 Earnings & Sales Beat, Reiterates View

Free Report) reported earnings of 3 cents per share in the third quarter of 2024. The Zacks...

Zacks 7 Nov 2024

Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get...

On Wednesday, Ark Invest, led by Cathie Wood, made significant trades in Moderna Inc. MRNA and Sq...

Benzinga 6 Nov 2024

Moderna (MRNA): Expanding Horizons in Gene Editing and mRNA Vaccines

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge...

Insider Monkey · via Yahoo Finance 1 Nov 2024

These are the S&P 500’s biggest laggards for October, down by as much as 29%

All price changes in this article exclude dividends. A.O. Smith Corp...Ticker October price chang...

MarketWatch · via Yahoo Finance 31 Oct 2024

Is Moderna, Inc. (MRNA) The Worst Performing S&P 500 Stock In 2024?

We recently published a list of the 10 Worst Performing Stocks in S&P 500 in 2024. In this articl...

Insider Monkey · via Yahoo Finance 31 Oct 2024